Abiopharma

(10% Negative) Sarepta Therapeutics Inc (SRPT) Announces Delay in revenue Trials for San Francisco Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Sarepta Reports Preliminary* Fourth Quarter and Full-Year 2025 Net Product Revenues

New Form D - Vireo Growth Inc. Filed: 2026-01-12 AccNo: 0001771706-26-000001 Size: 9 KB

(10% Negative) Lexeo Therapeutics Inc. (LXEO) Announces Delay in treatments Trials for cardiovascular diseases Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(91% Positive) Profound Medical Corp (PROF) Announces Clinical Development Update

Smith+Nephew PLC Notification

Investis Notification - Smith+Nephew PLC

New Form D - SOBR Safe, Inc. Filed: 2026-01-12 AccNo: 0001425627-26-000001 Size: 12 KB

Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

New Form 424B5 - China SXT Pharmaceuticals, Inc. Filed: 2026-01-12 AccNo: 0001213900-26-003205 Size: 328 KB

New Form 4/A - CROSS COUNTRY HEALTHCARE INC Filed: 2026-01-12 AccNo: 0001012975-26-000025 Size: 9 KB

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI

BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026